Abingworth as of Sept. 30, 2020
Portfolio Holdings for Abingworth
Abingworth holds 17 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 44.0 | $206M | 4.2M | 49.38 | |
| Personalis Common (PSNL) | 20.7 | $97M | 4.5M | 21.67 | |
| Phathom Common (PHAT) | 9.5 | $45M | 1.2M | 37.00 | |
| Soleno Common | 5.5 | $26M | 10M | 2.50 | |
| Crispr Namen Akt (CRSP) | 4.6 | $22M | 260k | 83.53 | |
| Nucana Ads | 3.7 | $17M | 3.3M | 5.17 | |
| Verona Sponds Adr (VRNA) | 3.3 | $15M | 2.5M | 6.24 | |
| Exicure Common | 2.6 | $12M | 7.0M | 1.73 | |
| Sierra Oncology Common | 2.0 | $9.2M | 877k | 10.51 | |
| Sientra Common | 1.7 | $8.1M | 2.4M | 3.40 | |
| Paratek Common | 1.2 | $5.6M | 1.0M | 5.40 | |
| Molecular Templates Common | 0.5 | $2.2M | 200k | 10.90 | |
| Aeglea Common | 0.4 | $1.7M | 241k | 7.08 | |
| Cymabay Common | 0.2 | $947k | 131k | 7.23 | |
| Protara Common | 0.1 | $344k | 21k | 16.69 | |
| Obseva Common | 0.0 | $218k | 88k | 2.48 | |
| Ocugen Common | 0.0 | $2.0k | 7.1k | 0.28 |
